Review promotion standards for the Research track.Hear from a representative cross-section of research track faculty who will discuss the various scholarly pathways that they have followed toward promotion, providing a sense of the range of independent and collaborative scholarship typical of faculty in the research track.Learn how these faculty ensured that they would be recognized for a unique contribution to the School’s research mission while simultaneously collaborating on other’s projects. Moderator: Dr. Lou Soslowsky; faculty panelists: Drs. Emer Smyth, Melpo Christofidou-Solomidou, and Akiva Cohen.
Title: Critical Care- Structure and Delivery
The Institute for Diabetes, Obesity, and Metabolism; the Division of Endocrinology, Diabetes, and Metabolism;
and the Diabetes Research Center Combined Fall 2011 Seminar Series presents:
The Endocrinology Clinical Case Conference and Grand Rounds Series presents:
Zubair Baloch, MD, PhD and Cytology Fellows
Title: "Interesting Pathology Cases"
Date: Wednesday, January 10, 2012
Time: 7:45 - 8:30 am
Location: G. Clayton Kyle Conference room - PCAM 4 West
Executive Vice-Dean Glen Gaulton will be speaking on Responsible Authorship
Vivian L. Smith Chair of Regenerative Medicine
Director, Stem Cells and Regenerative Medicine Center
Baylor College of Medicine
“Epigenetic regulation of hematopoietic stem cells”
Part of the Department of Genetics Faculty Search
Todd S. Macfarlan, Ph.D. Gene Expression Laboratory The Salk Institute
"Endogenous retroviruses coordinate gene expression and cell fate during embryonic development"
Dr. Chrispin Kambili will be giving a talk on "Pharmacaeutical Commerce & Health (In)Equality", as part of the new course NURS514 Globalization, Health & Health Care. For this special event any School of Nursing or Perelman School of Medicine student is welcome to sit in and listen.
Tuesday Feb 14th, 4:00 - 6:00 pm.
Dr. Chrispin Kambili is Global Medical Affairs Leader—Infectious Diseases at Johnson and Johnson, where he provides strategic guidance to infectious drug development teams.
Dr Kambili received his medical degree from Columbia University and completed his post-graduate training in internal medicine and in infectious diseases at New York Presbyterian Hospital of Columbia and Cornell in New York City.
Dr Kambili has previously worked at the New York City health department where he oversaw the provision of care at the ten public health clinics; participated in bioterrorism preparedness activities; and later served as Assistant Commissioner of Health and Director of the Bureau of Tuberculosis Control, in a US Centers for Disease Control & Prevention (CDC) assignment. Dr Kambili has also worked in Africa as the Field Medical Director for the International AIDS Vaccine Initiative (IAVI), based in Nairobi, Kenya. During his tenure at IAVI, he oversaw the creation of infrastructure for the conduct of all phases of HIV/AIDS vaccine clinical trials in several countries in eastern and southern Africa and led initiatives to improve access to HIV and other medical care around HIV vaccine clinical trial sites by liaising with Ministries of Health, non-governmental organizations, donors and local leaders and communities. Dr Kambili also worked as a Medical Director for the hepatitis and HIV programs at the then Schering Plough Pharmaceuticals now part of Merck.
Associate Dean for Research Professor of Immunology Department of Pathobiology School of Veterinary Medicine
"Immunity to leishmaniasis: It is not just about Th1 and Th2 cells anymore"